89 related articles for article (PubMed ID: 2902041)
1. Ovarian stimulation during gonadotropin treatment after hCG administration monitored by ultrasound and serum estradiol and progesterone.
Ylöstalo P; Siegberg R
Int J Fertil; 1988; 33(4):259-64. PubMed ID: 2902041
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
3. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
4. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
5. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
Steck T; Würfel W; Witteler M; Albert P
Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
[TBL] [Abstract][Full Text] [Related]
6. Response of IGF and IL-6 to ovarian stimulation in PCOS and normal women.
Liang FJ; Wu XK; Qu JW; Ke L; Sun J; Wang Y
Syst Biol Reprod Med; 2009 Dec; 55(5-6):227-35. PubMed ID: 19938957
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay.
Haning RV; Boehnlein LM; Carlson IH; Kuzma DL; Zweibel WJ
Fertil Steril; 1984 Dec; 42(6):882-9. PubMed ID: 6437878
[TBL] [Abstract][Full Text] [Related]
8. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
Ferin J; Thomas K; De Hertogh R
Acta Endocrinol Suppl (Copenh); 1977; 214():33-42. PubMed ID: 268747
[TBL] [Abstract][Full Text] [Related]
9. Elevtion of serum testosterone in ovarian hyperstimulation syndrome.
Schumert Z; Spitz I; Diamant Y; Polishuk WZ; Rabinowitz D
J Clin Endocrinol Metab; 1975 May; 40(5):889-92. PubMed ID: 1127095
[TBL] [Abstract][Full Text] [Related]
10. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
[TBL] [Abstract][Full Text] [Related]
11. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
[TBL] [Abstract][Full Text] [Related]
12. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
Ellenbogen A; David H; Libal Y; Ballas S
Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
[TBL] [Abstract][Full Text] [Related]
13. Induction of ovulation in polycystic ovarian disease.
Fleming R
Prog Clin Biol Res; 1986; 225():401-12. PubMed ID: 3097675
[No Abstract] [Full Text] [Related]
14. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
Tulandi T; McInnes RA; Arronet GH
Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
[TBL] [Abstract][Full Text] [Related]
15. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
[TBL] [Abstract][Full Text] [Related]
16. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
17. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
Vrtovec HM; Tomazevic T
J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
[TBL] [Abstract][Full Text] [Related]
18. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
19. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
[TBL] [Abstract][Full Text] [Related]
20. Premature luteinization defined by an increased progesterone/estradiol ratio on day of human chorionic gonadotropin administration is a manifestation of diminished ovarian responsiveness to controlled ovarian hyperstimulation.
Younis JS; Ben-Shlomo I; Ben-Ami M
Fertil Steril; 2010 Apr; 93(6):e29; author reply e30. PubMed ID: 20171620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
